MD Share Price Performance
US$19.88
5.29 (36.26%)
12.3% undervalued intrinsic discount
US$22.67
Fair Value
Price US$19.88
AnalystConsensusTarget US$22.67
AnalystLowTarget US$21.00
AnalystHighTarget US$24.00
Fair ValueUS$22.67
Share Pricen/a
Pediatrix Medical Group, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
MD Community Narratives
AN
Fair Value US$22.67 12.3% undervalued intrinsic discount
MD: Share Repurchase Plan And Margin Gains Will Support Future Performance
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value US$21 5.3% undervalued intrinsic discount
Rising Reimbursement Risks And Labor Shortages Will Erode Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$24 17.2% undervalued intrinsic discount
US Pediatric Growth And Telehealth Expansion Will Elevate NICU Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US Pediatric Growth And Telehealth Expansion Will Elevate NICU Care
Key Takeaways Leadership in high-acuity NICU care, strong negotiating leverage, and success in arbitration drive higher-than-expected revenue growth and margin expansion. Digital health investments, demographic tailwinds, and robust cash flow enable operational efficiencies, expansion, and strategic flexibility for acquisitions or buybacks.Read more
6
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$24
17.2% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
3.63% p.a.
Profit Margin
8.64%
Future PE
13.56x
Price in 2029
US$29.37
Rising Reimbursement Risks And Labor Shortages Will Erode Margins
Key Takeaways Intensifying reimbursement and regulatory pressures threaten revenue streams, margin stability, and long-term profitability as industry models shift away from traditional fee-for-service care. Physician shortages and growing dominance of hospital-owned practices heighten labor costs and weaken Pediatrix's negotiating leverage, challenging growth and retention efforts.Read more
6
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$21
5.3% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
4.35% p.a.
Profit Margin
7.83%
Future PE
12.63x
Price in 2029
US$25.68
MD: Share Repurchase Plan And Margin Gains Will Support Future Performance
Key Takeaways Growing demand for specialized pediatric and neonatal care, fueled by demographic and policy trends, is supporting recurring revenue and long-term stability. Operational efficiencies and financial flexibility are enabling margin expansion and positioning the company for strategic growth opportunities.Read more
64
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
US$22.67
12.3% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
3.56% p.a.
Profit Margin
8.04%
Future PE
13.57x
Price in 2028
US$27.63
Trending Discussion
Recently Updated Narratives
AN
MD: Higher Long Term Profitability Will Support Stronger Future Shareholder Returns
Fair Value: US$24 17.2% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
MD: Fair Outlook Will Depend On Steady Cash Flows And Completed Buybacks
Fair Value: US$21 5.3% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
MD: Stable Buybacks And Margins Will Support A Fair Future Outlook
Fair Value: US$22.67 12.3% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Pediatrix Medical Group, Inc. Key Details
About MD
- Founded
- 1979
- Employees
- 4280
- CEO
- WebsiteView website
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
